Reply to Chao Quan, Jinbo Chen, and Jiao Hu's Letter to the Editor re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14

Affiliations

¹ Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: basile.giuseppe@hsr.it.
² Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
³ Department of Oncology, IRCCS San Raffaele Hospital, Milan, Italy.

Comment

Giuseppe Basile et al. Eur Urol. 2023 Apr.

. 2023 Apr;83(4):e111-e112.

doi: 10.1016/j.eururo.2023.01.014. Epub 2023 Jan 25.

¹ Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: basile.giuseppe@hsr.it.
² Department of Urology, IRCCS San Raffaele Hospital, Milan, Italy.
³ Department of Oncology, IRCCS San Raffaele Hospital, Milan, Italy.

No abstract available

Comment on

Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Basile G, Bandini M, Gibb EA, Ross JS, Raggi D, Marandino L, Costa de Padua T, Crupi E, Colombo R, Colecchia M, Lucianò R, Nocera L, Moschini M, Briganti A, Montorsi F, Necchi A. Basile G, et al. Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158. Clin Cancer Res. 2022. PMID: 36190522 Clinical Trial.
Re: Giuseppe Basile, Marco Bandini, Ewan A. Gibb, et al. Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer: 3-Year Median Follow-up Update of PURE-01 Trial. Clin Cancer Res 2022;28:5107-14.
Quan C, Chen J, Hu J. Quan C, et al. Eur Urol. 2023 Apr;83(4):e109-e110. doi: 10.1016/j.eururo.2022.12.035. Epub 2023 Jan 24. Eur Urol. 2023. PMID: 36702694 No abstract available.